Tech Company Financing Transactions

Iconic Therapeutics Funding Round

Iconic Therapeutics, based in San Francisco, scored $40 million from Cormorant Asset Management, H.I.G. Capital and HBM Healthcare Investments.

Transaction Overview

Company Name
Iconic Therapeutics
Announced On
1/11/2016
Transaction Type
Venture Equity
Amount
$40,000,000
Round
Series C
Investors

Cormorant Asset Management

H.I.G. Capital (Bruce Robertson)

HBM Healthcare Investments (Matthias Fehr)

Lundbeckfond Ventures (Johan Kordel)

MPM Capital (Todd Foley)

Osage Partners

Proceeds Purpose
Proceeds from the financing will be used to advance development of lead molecule ICON-1 in retinal diseases as well as begin clinical trials in ocular melanoma, Iconic's first oncology indication. With new capital, Iconic expects to continue to add key talent to advance and expand the broad opportunities that may be addressed with a Tissue Factor-based approach.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
701 Gateway Blvd. 100
San Francisco, CA 94080
USA
Phone
(650) 437-1000
Website
www.iconictherapeutics.com
Email Address
[email protected]
Overview
Iconic Therapeutics develops and commercializes immunoconjugate proteins that trigger the immune system to destroy invader cells.
Profile
Iconic Therapeutics LinkedIn Company Profile
Social Media
Iconic Therapeutics Company Twitter Account
Company News
Iconic Therapeutics News
Facebook
Iconic Therapeutics on Facebook
YouTube
Iconic Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
William Greene
  William Greene LinkedIn Profile  William Greene Twitter Account  William Greene News  William Greene on Facebook
Chief Medical Officer
Gabriela Burian
  Gabriela Burian LinkedIn Profile  Gabriela Burian Twitter Account  Gabriela Burian News  Gabriela Burian on Facebook
Chief Operating Officer
Brandon Smith
  Brandon Smith LinkedIn Profile  Brandon Smith Twitter Account  Brandon Smith News  Brandon Smith on Facebook
VP - Operations
Cynthia Porter
  Cynthia Porter LinkedIn Profile  Cynthia Porter Twitter Account  Cynthia Porter News  Cynthia Porter on Facebook

 

 

Browse more venture capital transactions:

Prev: 1/11/2016: Grownetics venture capital transaction
Next: 1/11/2016: Dibs Technology venture capital transaction

 

Share this article

 

About Database of VC Transactions

Our team works diligently to report on all VC transactions involving tech companies. VC investment data records on this site are sourced from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.